Skip to main content

Closed

CRBU: Caribou Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-1175.7%

ROIC-100.4%

Financially safe

Stretched

Debt / equity0.26×

Interest coverage0.0×

Current ratio6.22×

Caribou Biosciences, Inc.

CRBUNASDAQ Global Select·USD·Closed

Caribou Biosciences, Inc.

CRBUNASDAQ·USD·Closed

$1.46

−3.31%

$1.46

−$0.05 (3.31%)

52W Range

4thpctl

Volume

0.56×avg

Mkt Cap

144.80MUSD

P/E

-1.0TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.56×avg

Market Cap

144.80MUSD

P/E Ratio

-1.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings